Drugs / Holy basil extract
Holy basil extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07175272 | Feb → Oct 2026 expected | dyspepsia | Mahidol University | Recruiting | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Holy basil extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07175272 ↗ |
| Known as | Holy basil | “Holy basil (Ocimum sanctum), or tulsi, is a traditional medicinal herb with anti-inflammatory and gastroprotective properties demonstrated in preclinical studies.” NCT07175272 ↗ |
| Known as | Ocimum sanctum | “Holy basil (Ocimum sanctum), or tulsi, is a traditional medicinal herb with anti-inflammatory and gastroprotective properties demonstrated in preclinical studies.” NCT07175272 ↗ |
| Known as | tulsi | “Holy basil (Ocimum sanctum), or tulsi, is a traditional medicinal herb with anti-inflammatory and gastroprotective properties demonstrated in preclinical studies.” NCT07175272 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Holy basil (Ocimum sanctum), or tulsi, is a traditional medicinal herb with anti-inflammatory and gastroprotective properties demonstrated in preclinical studies.” NCT07175272 ↗ |
| Route | Oral | “provided as an oral capsule formulation” NCT07175272 ↗ |